Optimal Clinical Trials - Central

Running trials

• Recruiting

  A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of RO7268489 as Add-on Therapy to Ocrelizumab, in Participants With Progressive Forms of Multiple Sclerosis (MS)

  NCT07282574· Phase 2· Source

• Active, not recruiting

  A Study to Evaluate the Safety and Efficacy of FB102 in Patients With Non-segmental Vitiligo

  NCT06905873· Phase 1· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Multiple sclerosis1 recruiting

Researchers

No researcher is linked here yet.